Stockscreener 앱 받기
1.36
0.00%
0.00
전일 마감가:
$1.36
열려 있는:
$1.33
하루 거래량:
14,155
Relative Volume:
0.07
시가총액:
$8.68M
수익:
$3.19M
순이익/손실:
$-10.42M
주가수익비율:
-0.0383
EPS:
-35.4757
순현금흐름:
$-10.65M
1주 성능:
+6.25%
1개월 성능:
+0.74%
6개월 성능:
-12.26%
1년 성능:
-46.88%
1일 변동 폭
$1.30
$1.38
1주일 범위
$1.1985
$1.4199
52주 변동 폭
$1.00
$3.04
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
명칭
Intelligent Bio Solutions Inc
전화
646-233-6971
주소
135 W 41ST ST,, NEW YORK
INBS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
1.37 | 8.68M | 3.19M | -10.42M | -10.65M | -35.48 |
|
ABT
Abbott Laboratories
|
132.22 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.51 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.21 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.41 | 108.80B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.40 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Intelligent Bio Solutions Inc 주식(INBS)의 최신 뉴스
Texas Capital Bancshares, Inc. (NASDAQ:TCBI) Given Average Rating of “Hold” by Analysts - American Banking and Market News
Intelligent Bio Solutions Adds Latin American Spanish To Drug Screening System To Expand Reach - Nasdaq
Intelligent Bio Solutions (INBS) Expands Language Options in Dru - GuruFocus
Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System | INBS Stock News - GuruFocus
Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System - The Manila Times
Intelligent Bio Solutions Expands Drug Screening Reach: Eyes Massive $1.1B Latin American Market Opportunity - Stock Titan
XTX Topco Ltd Buys New Position in Credit Acceptance Co. (NASDAQ:CACC) - American Banking and Market News
Intelligent Bio Solutions Files For Mixed Shelf Of Up To $100 MillionSEC Filing - MarketScreener
Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry - The Globe and Mail
Intelligent Bio Solutions (NASDAQ:INBS) Trading Up 7% – Time to Buy? - Defense World
Intelligent Bio Solutions Stock Drops Despite Key U.S. Patent Win - MSN
U.S. Patent Granted to Intelligent Bio Solutions for Drug Screening Tech - Medical Product Outsourcing
Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System - The Manila Times
Major Market Expansion: Drug Screening Tech Now Reaches 450 Million Arabic Speakers - Stock Titan
Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show - The Manila Times
Game-Changing Drug Testing Technology: Non-Invasive Solution Poised for Major US Launch - Stock Titan
MasterCard : Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry - MarketScreener
Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra - The Manila Times
Intelligent Bio Solutions Highlights Continued Expansion With Strategic Partnership In Spain And Andorra - MarketScreener
Major Expansion: Intelligent Bio Solutions Captures $448M Spanish Drug Testing Market with 1,000 Monthly Orders - Stock Titan
US patent granted for INBS’ fingerprint drug screening technology - Yahoo
Intelligent Bio Solutions secures new U.S. patent By Investing.com - Investing.com South Africa
Intelligent Bio Solutions Secures U.S. Patent for Drug Screening - TipRanks
Intelligent Bio Solutions secures new U.S. patent - Investing.com
Intelligent Bio Solutions Granted U.S. Patent For Fingerprinting Drug Screening Cartridge - Marketscreener.com
Revolutionary Fingerprint Drug Test Secures Game-Changing Patent for 2025 US Launch - Stock Titan
EXCLUSIVE: Intelligent Bio Solutions Adds Sixth US Patent For Its Drug Screening Technology - Benzinga
Intelligent Bio Solutions On Track For 2025 U.S. Launch Of FDA-Cleared Fingerprint Drug Test - Nasdaq
Intelligent Bio Solutions' FDA Clearance Process Remains on Track for 2025 U.S. Launch - The Manila Times
Intelligent Bio Solutions’ FDA Clearance Process Remains on Track for 2025 U.S. Launch - TradingView
Revolutionary Drug Screening System Achieves 94% Accuracy in FDA Submission Data - Stock Titan
EXCLUSIVE: FDA Seeks Additional Information For Intelligent Bio Solutions' Drug Screening System, Clearance Process Remains on Track For 2025 US Launch - Benzinga
Intelligent Bio Solutions Anticipates Sixth U.S. Patent Approval - TipRanks
iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025 - The Globe and Mail
Intelligent Bio Solutions Expecting to Get US Patent to Enhance Protection of Lateral Flow Technology - Marketscreener.com
Intelligent Bio Solutions Inc. Announces Anticipated Sixth Patent for Lateral Flow Technology in Drug Testing Solution - Nasdaq
Intelligent Bio Solutions set to secure new US patent - Investing.com
Intelligent Bio Solutions to Expand U.S. IP Portfolio with Expected Patent Grant - The Manila Times
Revolutionary Fingerprint Drug Test Patent Strengthens Intelligent Bio Solutions Market Position - Stock Titan
Intelligent Bio Solutions to Offer Additional Common Stock By Investing.com - Investing.com Australia
Intelligent Bio Solutions to Offer Additional Common Stock - Investing.com
Intelligent Bio Solutions to Participate in the iAccess Virtual Best Ideas Spring Conference on March 25th and 26th - The Manila Times
Intelligent Bio Solutions Reveals Growth Strategy at Elite Investor Conference March 25 - StockTitan
Intelligent Bio Solutions closes public offering of common stock - Medical Buyer
Intelligent Bio Solutions Inc (INBS) Should Be Considered For The Next Few Weeks - Stocks Register
Navient finalizes sale of Government Services business - The Manila Times
Intelligent Bio Solutions shares fall on proposed offering of common stock - MSN
Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter's Option to Purchase Additional Shares of Common Stock - The Manila Times
Intelligent Bio Solutions Inc. Closes $3 Million Public Offering of Common Stock - Nasdaq
Can This $3M Capital Raise Transform Intelligent Bio Solutions' Future? - StockTitan
Intelligent Bio Solutions announces pricing of $2.6 million public offering; shares fall - MSN
Intelligent Bio Solutions Inc (INBS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
10.11%
0.04%
자본화:
|
볼륨(24시간):